Phase II Clinical Development of New Drugs
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful exec...
Main Authors: | Ting, Naitee (Author), Chen, Ding-Geng (Author), Ho, Shuyen (Author), Cappelleri, Joseph C. (Author) |
---|---|
Corporate Author: | SpringerLink (Online service) |
Format: | Electronic eBook |
Language: | English |
Published: |
Singapore :
Springer Singapore : Imprint: Springer,
2017.
|
Series: | ICSA Book Series in Statistics,
|
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Similar Items
-
Modeling Dose-Response Microarray Data in Early Drug Development Experiments Using R Order-Restricted Analysis of Microarray Data /
Published: (2012) -
Group Sequential and Confirmatory Adaptive Designs in Clinical Trials
by: Wassmer, Gernot, et al.
Published: (2016) -
Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry
by: Burdick, Richard K., et al.
Published: (2017) -
Quantitative Decisions in Drug Development
by: Chuang-Stein, Christy, et al.
Published: (2017) -
New Drug Development An Introduction to Clinical Trials: Second Edition /
by: Turner, J. Rick
Published: (2010)